Mode
Text Size
Log in / Sign up

Bariatric surgery is associated with a significantly lower incidence of gallbladder cancer in people living with obesityWeight Loss Surgery Tied to Lower Gallbladder Cancer Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that bariatric surgery is associated with a significantly lower incidence of gallbladder cancer in patients with obesity.

This meta-analysis evaluated the relationship between bariatric surgery and the incidence of gallbladder cancer (GBC) among a large population of individuals living with obesity. The analysis included data from 3,929,395 participants to determine if surgical intervention for weight management correlates with reduced risk of this specific malignancy.

The primary outcome measured was the incidence of gallbladder cancer. The meta-analysis reported a significantly lower incidence of GBC in patients who underwent bariatric surgery compared to those who did not. The pooled effect size was reported as a relative risk (RR) of 0.35-0.90, with a 95% confidence interval of 0.35-0.90 and a p-value for heterogeneity of 0.014. This indicates a substantial reduction in the likelihood of GBC following bariatric procedures.

Several subgroup analyses were performed to refine these findings. In a subgroup consisting of studies with sample sizes under 50,000, the hazard ratio (HR) was reported as 0.45 (95% CI = 0.28-0.74). A univariate analysis also showed a lower risk with an HR of 0.48 (95% CI = 0.25-0.94). Furthermore, in the subgroup consisting of studies with a Newcastle-Ottawa Scale score greater than 6 points, the hazard ratio was reported as 0.6 (95% CI = 0.43-0.83). These consistent results across different filters suggest a robust association between bariatric surgery and reduced GBC incidence.

Safety and tolerability data were not reported. Consequently, specific adverse event rates, serious adverse events, or discontinuation rates following bariatric surgery for this specific outcome are not available within this analysis.

The evidence regarding bariatric surgery and gallbladder cancer is currently considered inconclusive. The study notes that effects vary significantly based on geographic region, total sample size of the included studies, adjustments made for confounding factors, and overall study quality. These variations suggest that while a trend toward lower risk exists, the magnitude and consistency of the effect may depend on specific clinical contexts.

Clinically, these results suggest that bariatric surgery may reduce the risk of gallbladder cancer in patients living with obesity. However, because the association is not established as causal, clinicians should interpret these findings as a potential protective benefit rather than a guaranteed outcome. The evidence remains preliminary and requires further validation through larger, long-term randomized controlled trials to confirm the observed benefits. Several questions remain unanswered regarding the mechanism of this reduction. It is unclear if the reduction in GBC risk is directly linked to weight loss, changes in metabolic markers, or other factors associated with bariatric surgery. Additionally, more data is needed to determine how these findings translate across different ethnicities and specific types of bariatric procedures.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap regarding the impact of weight management interventions on gallbladder cancer risk in patients with obesity. While previous reports have discussed surgical techniques such as robotic cholecystectomy for managing existing gallbladder cancer, this meta-analysis specifically explores the preventative role of bariatric surgery in the obese population.

A new meta-analysis looked at whether bariatric surgery, also known as weight loss surgery, can lower the chance of getting gallbladder cancer in people living with obesity. Gallbladder cancer is a rare but serious disease, and obesity is a known risk factor. The study combined results from several earlier studies to get a clearer picture.

The analysis included data from nearly 4 million people. It found that those who had bariatric surgery had a lower risk of developing gallbladder cancer compared to those who did not have the surgery. The risk reduction ranged from about 10% to 65%, depending on the study. This means that in some studies, the risk was cut by more than half.

However, the results were not the same across all studies. The benefit was more clear in studies with fewer than 50,000 participants, in those that used simpler statistical methods, and in studies rated as higher quality. This suggests that the true effect may vary based on how the studies were done and the characteristics of the people in them.

It is important to note that this type of study can show an association but cannot prove that surgery directly causes the lower cancer risk. Other factors, such as changes in diet, hormones, or inflammation after surgery, might also play a role. The researchers call for larger, long-term studies to confirm these findings.

For people living with obesity, bariatric surgery is already known to help with weight loss and improve many health conditions, such as diabetes and heart disease. This study adds that it might also help protect against gallbladder cancer. However, the decision to have surgery should be made with a doctor, considering all the benefits and risks.

In summary, this large analysis found that bariatric surgery is linked to a lower risk of gallbladder cancer in people with obesity. While the evidence is promising, it is not yet strong enough to recommend surgery solely for cancer prevention. More research is needed to understand who benefits most and how long the protection lasts.

What this means for you:
Bariatric surgery may lower gallbladder cancer risk in people with obesity, but more research is needed to confirm.

Study Details

Study typeMeta analysis
Sample sizen = 3,929,395
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Recent studies suggest bariatric surgery might protect against gallbladder cancer (GBC), but evidence is inconclusive. We conducted a meta-analysis of cohort studies identified through PubMed, Embase, and Cochrane Library. Random-effects models generated pooled risk ratios (RR) with 95% confidence intervals (CI), and heterogeneity was assessed with Cochran's Q and I². Ten cohort studies totaling 3,929,395 participants were included. Bariatric surgery was associated with a significantly lower incidence of GBC (95% CI = 0.35-0.90), with moderate heterogeneity (P = 0.014; I²=56.5%). Leave-one-out sensitivity analyses confirmed robustness. In the subgroup analyses by the size of the surgical sample, the pooled HR was 0.45 (95% CI = 0.28-0.74) for less than 50,000. In the subgroup analyses by analysis method, the pooled HR was 0.48 (95% CI = 0.25-0.94) for Univariate analysis. Moreover, in studies with Newcastle-Ottawa Scale(NOS), HR was 0.6 (95% CI = 0.43-0.83) for more than 6 points. Overall, bariatric surgery may reduce GBC risk, but effects vary by region, sample size, confounding adjustment, and study quality. KEY POINTS: • Bariatric surgery is associated with a reduced risk of GBC in people living with obesity. • The protective association is more evident in specific subgroups and remains robust across sensitivity analyses. • Larger, long-term RCTs are required to confrm benefts.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.